A Comprehensive Review on Niosomes in Drug Delivery and Recent Advancements
Abstract
The recent emphasis on nanocarrier development for drug delivery stems from the need to target specific diseased areas while sparing healthy tissues. Effective and safe drug administration has long posed challenges in medicine. Over the past decade, the emergence of vesicles as a means to enhance drug delivery has captivated researchers in the field of drug delivery systems. Among vesicular systems, niosomes have gained attention due to their nonionic features. Unlike liposomes, niosomes offer superior stability, making them a preferred choice. Non-ionic in nature niosomes offer unique advantages in drug delivery providing a versatile platform for encapsulating various drugs to enhance bioavailability and ensure controlled release. Understanding preparation techniques enables tailored applications from oral to transdermal delivery. Characterization methods such as morphology and particles size are pivotal in ensuring the stability and effectiveness of niosomes. Applications span cancer therapy, diagnostic imaging, and vaccination adjuvants, showcasing niosomes versatility. Ongoing research reflects dynamic efforts to enhance capabilities, emphasizing their pivotal role in evolving drug delivery systems. In this comprehensive review, we aim to encapsulate fundamental aspects of niosomes, encompassing diverse preparation methods, various niosomal types, methods for characterization and the advancements witnessed in niosomal research over the past decade, drawing insights from a literature review.
Keywords: Niosomes, Drug delivery, Nanocarrier, Vesicles, Nanomedicines
Keywords:
Niosomes, Drug delivery, Nanocarrier, Vesicles, NanomedicinesDOI
https://doi.org/10.22270/jddt.v14i6.6651References
Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S, Carafa M. Niosomes from 80s to present: the state of the art. Advances in colloid and interface science. 2014 Mar 1;205:187-206. DOI: https://doi.org/10.1016/j.cis.2013.11.018
Ag Seleci D, Seleci M, Walter JG, Stahl F, Scheper T. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. Journal of nanomaterials. 2016 Oct;2016. DOI: https://doi.org/10.1155/2016/7372306
Soni RA, Rizwan MA, Singh S. Opportunities and potential of green chemistry in nanotechnology. Nanotechnology for Environmental Engineering. 2022 Sep;7(3):661-73. DOI: https://doi.org/10.1007/s41204-022-00233-5
Kanwar R, Rathee J, Salunke DB, Mehta SK. Green nanotechnology-driven drug delivery assemblies. ACS omega. 2019 May 22;4(5):8804-15. DOI: https://doi.org/10.1021/acsomega.9b00304
Malik S, Muhammad K, Waheed Y. Emerging applications of nanotechnology in healthcare and medicine. Molecules. 2023 Sep 14;28(18):6624. DOI: https://doi.org/10.3390/molecules28186624
Kántor I, Dreavă D, Todea A, Péter F, May Z, Biró E, Babos G, Feczkó T. Co-Entrapment of Sorafenib and Cisplatin Drugs and iRGD Tumour Homing Peptide by Poly [ε-caprolactone-co-(12-hydroxystearate)] Copolymer. Biomedicines. 2021 Dec 26;10(1):43. DOI: https://doi.org/10.3390/biomedicines10010043
Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The history of nanoscience and nanotechnology: from chemical–physical applications to nanomedicine. Molecules. 2019 Dec 27;25(1):112. DOI: https://doi.org/10.3390/molecules25010112
Mbunge E, Muchemwa B, Batani J. Sensors and healthcare 5.0: transformative shift in virtual care through emerging digital health technologies. Global Health Journal. 2021 Dec 1;5(4):169-77. DOI: https://doi.org/10.1016/j.glohj.2021.11.008
Anjum S, Ishaque S, Fatima H, Farooq W, Hano C, Abbasi BH, Anjum I. Emerging applications of nanotechnology in healthcare systems: Grand challenges and perspectives. Pharmaceuticals. 2021 Jul 21;14(8):707. DOI: https://doi.org/10.3390/ph14080707
Liga S, Paul C, Moacă EA, Péter F. Niosomes: Composition, Formulation Techniques, and Recent Progress as Delivery Systems in Cancer Therapy. Pharmaceutics. 2024 Feb 4;16(2):223. DOI: https://doi.org/10.3390/pharmaceutics16020223
Prajapati SK, Maurya SD, Das MK, Tilak VK, Verma KK, Dhakar RC, Dendrimers in drug delivery, diagnosis and therapy: basics and potential applications, Journal of Drug Delivery and Therapeutics, 2016;6(1)67-92. https://doi.org/10.22270/jddt.v6i1.1190
Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, Vader P. Extracellular vesicles as drug delivery systems: Why and how?. Advanced drug delivery reviews. 2020 Jan 1;159:332-43. DOI: https://doi.org/10.1016/j.addr.2020.04.004
Kauslya A, Borawake PD, Shinde JV, Chavan RS. Niosomes: a novel carrier drug delivery system. Journal of Drug Delivery and Therapeutics. 2021 Jan 15;11(1):162-70. DOI: https://doi.org/10.22270/jddt.v11i1.4479
Maja L, Željko K, Mateja P. Sustainable technologies for liposome preparation. The Journal of Supercritical Fluids. 2020 Nov 1;165:104984. DOI: https://doi.org/10.1016/j.supflu.2020.104984
Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. Journal of drug targeting. 2009 Nov 1;17(9):671-89. DOI: https://doi.org/10.3109/10611860903079454
Maurya SD, Prajapati S, Gupta A, Saxena G, Dhakar RC, Formulation development and evaluation of ethosome of stavudine, Int J Pharm Edu Res 2010;13(16).
Chandu VP, Arunachalam A, Jeganath S, Yamini K, Tharangini K, Chaitanya G. Niosomes: a novel drug delivery system. International journal of novel trends in pharmaceutical sciences. 2012 Feb;2(1):25-31.
Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Journal of controlled release. 2014 Jul 10;185:22-36. DOI: https://doi.org/10.1016/j.jconrel.2014.04.015
Sahin NO. Niosomes as nanocarrier systems. Nanomaterials and nanosystems for biomedical applications. 2007:67-81. DOI: https://doi.org/10.1007/978-1-4020-6289-6_4
Umbarkar MG. Niosome as a Novel Pharmaceutical Drug Delivery: A Brief Review Highlighting Formulation, Types, Composition and Application. Indian Journal of Pharmaceutical Education & Research. 2021 Jan 2;55. DOI: https://doi.org/10.5530/ijper.55.1s.34
Yeo PL, Lim CL, Chye SM, Ling AP, Koh RY. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomedicine. 2017 Aug 1;11(4):301-14. DOI: https://doi.org/10.1515/abm-2018-0002
Srivastava RC, Nagappa AN. Surface activity in drug action. Elsevier; 2005 Mar 1.
Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta pharmaceutica sinica B. 2011 Dec 1;1(4):208-19. DOI: https://doi.org/10.1016/j.apsb.2011.09.002
Mouritsen OG, Zuckermann MJ. What's so special about cholesterol?. Lipids. 2004 Nov;39(11):1101-13. DOI: https://doi.org/10.1007/s11745-004-1336-x
Bhardwaj P, Tripathi P, Gupta R, Pandey S. Niosomes: A review on niosomal research in the last decade. Journal of Drug Delivery Science and Technology. 2020 Apr 1;56:101581. DOI: https://doi.org/10.1016/j.jddst.2020.101581
Sharma A, Kumar L, Kumar P, Prasad N, Rastogi V. Niosomes: a promising approach in drug delivery systems. Journal of Drug Delivery and Therapeutics. 2019 Jul 15;9(4):635-42. DOI: https://doi.org/10.22270/jddt.v9i4.3064
Mishra V, Nayak P, Singh M, Sriram P, Suttee A. Niosomes: potential nanocarriers for drug delivery. J Pharm Clin Res. 2020;11(03):389-94. DOI: https://doi.org/10.25258/ijpqa.11.3.13
Mehta S. Anti-cancer drugs targeting using nanocarrier niosomes-a review. TMR Cancer. 2020;3(4):169-74. DOI: https://doi.org/10.12032/TMRC201800078
Kulkarni P, Rawtani D. Application of box-behnken design in the preparation, optimization, and in vitro evaluation of self-assembly–based tamoxifen-and doxorubicin-loaded and dual drug–loaded niosomes for combinatorial breast cancer treatment. Journal of pharmaceutical sciences. 2019 Aug 1;108(8):2643-53. DOI: https://doi.org/10.1016/j.xphs.2019.03.020
Chen S, Hanning S, Falconer J, Locke M, Wen J. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications. European journal of pharmaceutics and biopharmaceutics. 2019 Nov 1;144:18-39. DOI: https://doi.org/10.1016/j.ejpb.2019.08.015
Gugleva V, Titeva S, Rangelov S, Momekova D. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system. International journal of pharmaceutics. 2019 Aug 15;567:118431. DOI: https://doi.org/10.1016/j.ijpharm.2019.06.022
Khatoon M, Shah KU, Din FU, Shah SU, Rehman AU, Dilawar N, Khan AN. Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Drug delivery. 2017 Nov 1;24(2):56-69. DOI: https://doi.org/10.1080/10717544.2017.1384520
Tran YT, Tran GN, Hoang AL, Vu GT. Niosomes loaded with diclofenac for transdermal administration: Physico-chemical characterization, ex vivo and in vivo skin permeation studies. Journal of applied pharmaceutical science. 2020 Dec 5;10(12):053-61. DOI: https://doi.org/10.7324/JAPS.2020.101207
Khoee S, Yaghoobian M. Niosomes: A novel approach in modern drug delivery systems. InNanostructures for drug delivery 2017 Jan 1 (pp. 207-237). Elsevier. DOI: https://doi.org/10.1016/B978-0-323-46143-6.00006-3
Sadeghi-Ghadi Z, Ebrahimnejad P, Talebpour Amiri F, Nokhodchi A. Improved oral delivery of quercetin with hyaluronic acid containing niosomes as a promising formulation. Journal of drug targeting. 2021 Feb 7;29(2):225-34. DOI: https://doi.org/10.1080/1061186X.2020.1830408
Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, Fazeli MR, Jamalifar H. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. Journal of microencapsulation. 2010 Nov 1;27(7):618-27. DOI: https://doi.org/10.3109/02652048.2010.506579
Mohamad Saimi NI, Salim N, Ahmad N, Abdulmalek E, Abdul Rahman MB. Aerosolized niosome formulation containing gemcitabine and cisplatin for lung cancer treatment: Optimization, characterization and in vitro evaluation. Pharmaceutics. 2021 Jan 5;13(1):59. DOI: https://doi.org/10.3390/pharmaceutics13010059
Abou-Taleb HA, Khallaf RA, Abdel-Aleem JA. Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation. Drug design, development and therapy. 2018 Oct 17:3501-16. DOI: https://doi.org/10.2147/DDDT.S177746
Teaima MH, El Mohamady AM, El-Nabarawi MA, Mohamed AI. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery. Drug development and industrial pharmacy. 2020 May 3;46(5):751-61. DOI: https://doi.org/10.1080/03639045.2020.1753061
Pardakhty A, Moazeni E. Nano-niosomes in drug, vaccine and gene delivery: a rapid overview. Nanomedicine Journal. 2013 Oct 1;1(1):1-2. DOI: https://doi.org/10.22038/NMJ.2013.697
Brewer JM, Alexander J. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology. 1992 Apr;75(4):570.
Carballo-Pedrares N, Kattar A, Concheiro A, Alvarez-Lorenzo C, Rey-Rico A. Niosomes-based gene delivery systems for effective transfection of human mesenchymal stem cells. Materials Science and Engineering: C. 2021 Sep 1;128:112307. DOI: https://doi.org/10.1016/j.msec.2021.112307
Jain AP, Sharma P, Pandey P, Gupta R, Roshan S, Garg A, Sahu A, Jain A. Niosome a novel approach for drug delivery system: an overview. Asian J Pharm Sci Res. 2013;3(5):18-30.
Rathee J, Kanwar R, Kaushik D, Salunke DB, Mehta SK. Niosomes as efficient drug delivery modules for encapsulation of Toll-like receptor 7 agonists and IDO-inhibitor. Applied Surface Science. 2020 Mar 1;505:144078. DOI: https://doi.org/10.1016/j.apsusc.2019.144078
Fallarini S, Papi F, Licciardi F, Natali F, Lombardi G, Maestrelli F, Nativi C. Niosomes as Biocompatible Scaffolds for the Multivalent Presentation of Tumor-Associated Antigens (TACAs) to the Immune System. Bioconjugate Chemistry. 2022 Dec 15;34(1):181-92. DOI: https://doi.org/10.1021/acs.bioconjchem.2c00383
Demir B, Barlas FB, Gumus ZP, Unak P, Timur S. Theranostic niosomes as a promising tool for combined therapy and diagnosis:“All-in-One” Approach. ACS Applied Nano Materials. 2018 Jun 1;1(6):2827-35. DOI: https://doi.org/10.1021/acsanm.8b00468
Ag Seleci D, Maurer V, Barlas FB, Porsiel JC, Temel B, Ceylan E, Timur S, Stahl F, Scheper T, Garnweitner G. Transferrin-decorated niosomes with integrated InP/ZnS quantum dots and magnetic iron oxide nanoparticles: dual targeting and imaging of glioma. International journal of molecular sciences. 2021 Apr 27;22(9):4556. DOI: https://doi.org/10.3390/ijms22094556
Mawazi SM, Ann TJ, Widodo RT. Application of niosomes in cosmetics: a systematic review. Cosmetics. 2022 Nov 25;9(6):127. DOI: https://doi.org/10.3390/cosmetics9060127
Al Jayoush AR, Hassan HA, Asiri H, Jafar M, Saeed R, Harati R, Haider M. Niosomes for nose-to-brain delivery: a non-invasive versatile carrier system for drug delivery in neurodegenerative diseases. Journal of Drug Delivery Science and Technology. 2023 Sep 28:105007. DOI: https://doi.org/10.1016/j.jddst.2023.105007.
Kulkarni P, Rawtani D, Barot T. Design, development and in-vitro/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer’s disease. European journal of pharmaceutics and biopharmaceutics. 2021 Jun 1;163:1-5. DOI: https://doi.org/10.1016/j.ejpb.2021.02.015
Mirzaie A, Peirovi N, Akbarzadeh I, Moghtaderi M, Heidari F, Yeganeh FE, Noorbazargan H, Mirzazadeh S, Bakhtiari R. Preparation and optimization of ciprofloxacin encapsulated niosomes: A new approach for enhanced antibacterial activity, biofilm inhibition and reduced antibiotic resistance in ciprofloxacin-resistant methicillin-resistance Staphylococcus aureus. Bioorganic chemistry. 2020 Oct 1;103:104231. DOI: https://doi.org/10.1016/j.bioorg.2020.104231
Hedayati Ch M, Abolhassani Targhi A, Shamsi F, Heidari F, Salehi Moghadam Z, Mirzaie A, Behdad R, Moghtaderi M, Akbarzadeh I. Niosome‐encapsulated tobramycin reduced antibiotic resistance and enhanced antibacterial activity against multidrug‐resistant clinical strains of Pseudomonas aeruginosa. Journal of Biomedical Materials Research Part A. 2021 Jun;109(6):966-80. DOI: https://doi.org/10.1002/jbm.a.37086
Kashef MT, Saleh NM, Assar NH, Ramadan MA. The antimicrobial activity of ciprofloxacin-loaded niosomes against ciprofloxacin-resistant and biofilm-forming Staphylococcus aureus. Infection and Drug Resistance. 2020 Jun 8:1619-29. DOI: https://doi.org/10.2147/IDR.S249628
Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, Akbarzadeh I, Hejabi F, Abtahi MS, Ren Q. Current advances in niosomes applications for drug delivery and cancer treatment. Materials Today Bio. 2023 Oct 21:100837. DOI: https://doi.org/10.1016/j.mtbio.2023.100837
Owodeha-Ashaka K, Ilomuanya MO, Iyire A. Evaluation of sonication on stability-indicating properties of optimized pilocarpine hydrochloride-loaded niosomes in ocular drug delivery. Progress in biomaterials. 2021 Sep;10:207-20. DOI: https://doi.org/10.1007/s40204-021-00164-5
Junyaprasert VB, Teeranachaideekul V, Supaperm T. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS pharmscitech. 2008 Sep;9:851-9. DOI: https://doi.org/10.1208/s12249-008-9121-1
Kulkarni AS, Jadhav AN, Babar CV, Patil SR, Mirajkar ND, Jadhav SD. Design and characterization of zanamivir loaded niosomes. World J. Pharm. Res.. 2020 Jun 22;9:2485-515. DOI: https://doi.org/10.20959/wjpr20208-18343
Abou-Taleb HA, Khallaf RA, Abdel-Aleem JA. Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation. Drug design, development and therapy. 2018 Oct 17:3501-16. DOI: https://doi.org/10.2147/DDDT.S177746
Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. International journal of pharmaceutics. 2007 Jan 10;328(2):130-41. DOI: https://doi.org/10.1016/j.ijpharm.2006.08.002
Arora R, Chawla R, Marwah R, Arora P, Sharma RK, Kaushik V, Goel R, Kaur A, Silambarasan M, Tripathi RP, Bhardwaj JR. Potential of complementary and alternative medicine in preventive management of novel H1N1 flu (Swine flu) pandemic: thwarting potential disasters in the bud. Evidence-Based complementary and alternative medicine. 2010;2011. DOI: https://doi.org/10.1155/2011/586506
Vangala A, Kirby D, Rosenkrands I, Agger EM, Andersen P, Perrie Y. A comparative study of cationic liposome and niosome‐based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice. Journal of pharmacy and pharmacology. 2006 Jun;58(6):787-99. DOI: https://doi.org/10.1211/jpp.58.6.0009
Dufes C, Schätzlein AG, Tetley L, Gray AI, Watson DG, Olivier JC, Couet W, Uchegbu IF. Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting. Pharmaceutical research. 2000 Oct;17:1250-8. DOI: https://doi.org/10.1023/A:1026422915326
Luciani A, Olivier JC, Clement O, Siauve N, Brillet PY, Bessoud B, Gazeau F, Uchegbu IF, Kahn E, Frija G, Cuenod CA. Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. Radiology. 2004 Apr;231(1):135-42. DOI: https://doi.org/10.1148/radiol.2311021559
Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. Journal of pharmaceutical sciences. 2010 Apr 1;99(4):2049-60. DOI: https://doi.org/10.1002/jps.21944
Thabet Y, Elsabahy M, Eissa NG. Methods for preparation of niosomes: A focus on thin-film hydration method. Methods. 2022 Mar 1;199:9-15. DOI: https://doi.org/10.1016/j.ymeth.2021.05.004
Tangri P, Khurana S. Niosomes: Formulation and evaluation. International Journal. 2011;2229:7499.
Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, Kuotsu K. Niosome: a future of targeted drug delivery systems. Journal of advanced pharmaceutical technology & research. 2010 Oct 1;1(4):374-80. DOI: https://doi.org/10.4103/0110-5558.76435
Durak S, Esmaeili Rad M, Alp Yetisgin A, Eda Sutova H, Kutlu O, Cetinel S, Zarrabi A. Niosomal drug delivery systems for ocular disease—Recent advances and future prospects. Nanomaterials. 2020 Jun 18;10(6):1191. DOI: https://doi.org/10.3390/nano10061191
Ag Seleci D, Maurer V, Stahl F, Scheper T, Garnweitner G. Rapid microfluidic preparation of niosomes for targeted drug delivery. International journal of molecular sciences. 2019 Sep 22;20(19):4696. DOI: https://doi.org/10.3390/ijms20194696
Durga B, Veera L. Recent advances of non-ionic surfactant-based nano-vesicles (niosomes and proniosomes): A brief review of these in enhancing transdermal delivery of drug. Futur J Pharm Sci. 2020;6:100. DOI: https://doi.org/10.1186/s43094-020-00117-y
Nikam NR, Patil PR, Vakhariya RR, Magdum CS. Liposomes: A novel drug delivery system: An overview. Asian journal of pharmaceutical research. 2020;10(1):23-8. DOI: https://doi.org/10.5958/2231-5691.2020.00005.2
Bartelds R, Nematollahi MH, Pols T, Stuart MC, Pardakhty A, Asadikaram G, Poolman B. Niosomes, an alternative for liposomal delivery. PLoS One. 2018 Apr 12;13(4):e0194179. DOI: https://doi.org/10.1371/journal.pone.0194179
Jain S, Singh P, Mishra V, Vyas SP. Mannosylated niosomes as adjuvant–carrier system for oral genetic immunization against Hepatitis B. Immunology letters. 2005 Oct 15;101(1):41-9. DOI: https://doi.org/10.1016/j.imlet.2005.04.002
Devaraj GN, Parakh SR, Devraj R, Apte SS, Rao BR, Rambhau D. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. Journal of colloid and interface science. 2002 Jul 15;251(2):360-5. DOI: https://doi.org/10.1006/jcis.2002.8399
Bhaskaran S, Lakshmi PK. Comparative evaluation of niosome formulations prepared by different techniques. Acta Pharmaceutica Sciencia. 2009;51(1).
Celia C, Trapasso E, Cosco D, Paolino D, Fresta M. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids and Surfaces B: Biointerfaces. 2009 Aug 1;72(1):155-60. DOI: https://doi.org/10.1016/j.colsurfb.2009.03.007
Ge X, Wei M, He S, Yuan WE. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics. 2019 Jan 29;11(2):55. DOI: https://doi.org/10.3390/pharmaceutics11020055
Verma S, Singh SK, Syan N, Mathur P, Valecha V. Nanoparticle vesicular systems: a versatile tool for drug delivery. J Chem Pharm Res. 2010;2(2):496-509.
Aparajay P, Dev A. Functionalized niosomes as a smart delivery device in cancer and fungal infection. European Journal of Pharmaceutical Sciences. 2022 Jan 1;168:106052. DOI: https://doi.org/10.1016/j.ejps.2021.106052
Shilpa S, Srinivasan BP, Chauhan M. Niosomes as vesicular carriers for delivery of proteins and biologicals. International Journal of Drug Delivery. 2011 Jan 1;3(1). DOI: https://doi.org/10.5138/ijdd.2010.0975.0215.03050
Escudero I, Geanta RM, Ruiz MO, Benito JM. Formulation and characterization of Tween 80/cholestherol niosomes modified with tri-n-octylmethylammonium chloride (TOMAC) for carboxylic acids entrapment. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2014 Nov 5;461:167-77. DOI: https://doi.org/10.1016/j.colsurfa.2014.07.042
Akbarzadeh I, Sedaghatnia K, Bourbour M, Moghaddam Z, Moghtaderi M, Samimi-Sohrforozani E, Quazi S, Far B. Niosomes: a novel targeted drug delivery system. 2021 DOI: https://doi.org/10.20944/preprints202112.0315.v1
Yue PF, Lu XY, Zhang ZZ, Yuan HL, Zhu WF, Zheng Q, Yang M. The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion. Aaps Pharmscitech. 2009 Jun;10:376-83. DOI: https://doi.org/10.1208/s12249-009-9216-3
Bahrololoumi S, Nikazar S. Niosomes as a promising nanovesicular drug delivery. InAdvanced and Modern Approaches for Drug Delivery 2023 Jan 1 (pp. 223-258). Academic Press. DOI: https://doi.org/10.1016/B978-0-323-91668-4.00011-3
Karki R, Mamatha GC, Subramanya G, Udupa N. Preparation, characterization and tissue disposition of niosomes containing isoniazid. 2008
Yadav JD, Kulkarni PR, Vaidya KA, Shelke GT. Niosomes: a review. Journal of Pharmacy Research. 2011 Mar;4(3):632-6. DOI: https://doi.org/10.22270/ajprd.v11i4.1295
Published
Abstract Display: 602 
PDF Downloads: 443 PDF Downloads: 52 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.